Remove 2027 Remove Healthcare Provider Remove Side effects
article thumbnail

How to Successfully Market Your GLP-1 Program: Strategies for Standing Out

LEVO Health

billion by 2027. This growth presents a significant opportunity for healthcare organizations and businesses, but it also means the market is becoming increasingly saturated. Educational Content Provide patients with comprehensive information about GLP-1 medications, their benefits, potential side effects, and how they work.

article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually. In the past, obesity medications were often dismissed due to insufficient efficacy data and the fact that they were associated with a high occurrence of side effects.

Medical 105
article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually. In the past, obesity medications were often dismissed due to insufficient efficacy data and the fact that they were associated with a high occurrence of side effects.

Medical 98